A drug used by women with osteoporosis has been approved to prevent fractures in cancer patients treated with hormones. But recent studies show that silent fractures often exist even before the hormone therapy starts.
Not enough people at risk of osteoporosis are getting DXA scans as recommended, because of changes in Medicare reimbursement. Meanwhile, it's being marketed to fitness enthusiasts as a way to assess body composition, even before it has been well validated for that purpose.
The prevalence of secondary osteoporosis in men is similar to that in women and is significantly lower than is often reported.
Osteoporosis often remains undiagnosed until the patient turns up with a fracture. German researchers have developed a medical history questionnaire that they say can accurately predict which patients have osteoporosis.
The level of osteoporosis knowledge is low among patients with fractures in spite of a high volume of available information.
Regional cancellous bone mineral density (BMD) can be approximated from Hounsfield units (HU) measured on CT examinations using automatic exposure control; this information is reliable and follows a predictable pattern with increasing age.
Close to 70% of women who responded thought that the disease can be prevented, but only 50% recognized exercise as a method of osteoporosis prevention.
Osteoporosis is a disease in which the bones lose their content of minerals, particularly calcium. When this occurs, the bones become weakened an prone to fracture. Common sites of fracture include the spine, hip, ribs, and wrist.
The incidence of ankle fractures in the older patient population is rising. These fractures are characterized as fragility fractures associated with osteoporosis, but propensity for falls, increased weight, and polypharmacy may be bigger risk factors than poor bone quality.
(AUDIO) That’s the question we put to Dr. Kenneth Saag. In the next few minutes, Dr. Saag, will summarize the latest developments in osteoporosis therapy.